Identifying population-based eGFR distributions may help to identify patients at risk for developing chronic kidney disease earlier, according to study data published in Kidney International. More ...

On Friday, Novartis AG NVS shared final results from the Phase 3 ALIGN study supporting a slowing decline in kidney function in adults with IgA nephropathy (IgAN) who were treated with Vanrafia ...

Kidneys work quietly in the background, filtering waste, balancing fluids, and maintaining chemical stability without demanding attention. But this is until som ...

Kidney problems never or rarely announce themselves loudly. There is no sudden pain or obvious warning in the early stages, which often makes it difficult to re ...

In unadjusted analysis, rates of DKA among individuals with an eGFR between 30 and 90 mL/min/1.73 m 2 showed no statistical difference compared with those with an eGFR between 90 and 120 mL/min/1.73 m ...

MediBeacon ® Transdermal GFR System is a first-in-kind product for point of care kidney function assessment Centers of Excellence ...

Even "normal" kidney test results may mask hidden risks if theyre unusually low for your age and sex, signaling higher ...

Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, ...

ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...

Understanding eGFR and uPCR is vital for managing IgA nephropathy to predict kidney health, guide treatment, and work effectively with healthcare providers in slowing disease progression.

A virus that officials say “has a relatively high death rate” has led to COVID-style health checks at several airports in Asia. Five people in in West Bengal, India, have contracted the Nipah virus, ...